# Official Journal C 268/28 O

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 268 |
| | |
| English edition | Information and Notices | Volume 4828 October 2005 |

ISSN 1725-2423

Official Journal

of the European Union

C 268

English edition

Information and Notices

Volume 4828 October 2005

---

| Notice No | Contents | page |
| --- | --- | --- |
| | I   Information |
| | Commission |
| 2005/C 268/1 | Euro exchange rates | 1 |
| 2005/C 268/2 | Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 September 2005 to 30 September 2005(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93) | 2 |
| 2005/C 268/3 | Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 September 2005 to 30 September 2005(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC) | 7 |
| 2005/C 268/4 | Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 68/2001 of 12 January 2001 on the application of Articles 87 and 88 of the EC Treaty to training aid (
  1
  ) | 10 |
| 2005/C 268/5 | Uniform application of the Combined Nomenclature (CN) (Classification of goods) | 13 |
| 2005/C 268/6 | Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 70/2001 of 12 January 2001 on the application of Articles 87 and 88 of the EC Treaty to State aid to small and medium-sized enterprises (
  1
  ) | 14 |
| 2005/C 268/7 | Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 2204/2002 of 12 December 2002 on the application of Articles 87 and 88 of the EC Treaty to State aid for employment (
  1
  ) | 15 |
| 2005/C 268/8 | Non-opposition to a notified concentration (Case COMP/M.3735 — Finmeccanica/AMS) (
  1
  ) | 16 |
| 2005/C 268/9 | Non-opposition to a notified concentration (Case COMP/M.3649 — Finmeccanica/Baes Avionics & Communications) (
  1
  ) | 16 |

Notice No

Contents

page

I   Information

Commission

2005/C 268/1

Euro exchange rates

1

2005/C 268/2

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 September 2005 to 30 September 2005(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)

(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)

2

2005/C 268/3

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 September 2005 to 30 September 2005(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

7

2005/C 268/4

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 68/2001 of 12 January 2001 on the application of Articles 87 and 88 of the EC Treaty to training aid (
  1
  )

1

10

2005/C 268/5

Uniform application of the Combined Nomenclature (CN) (Classification of goods)

13

2005/C 268/6

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 70/2001 of 12 January 2001 on the application of Articles 87 and 88 of the EC Treaty to State aid to small and medium-sized enterprises (
  1
  )

1

14

2005/C 268/7

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 2204/2002 of 12 December 2002 on the application of Articles 87 and 88 of the EC Treaty to State aid for employment (
  1
  )

1

15

2005/C 268/8

Non-opposition to a notified concentration (Case COMP/M.3735 — Finmeccanica/AMS) (
  1
  )

1

16

2005/C 268/9

Non-opposition to a notified concentration (Case COMP/M.3649 — Finmeccanica/Baes Avionics & Communications) (
  1
  )

1

16

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN

---

I Information

Commission

| 28.10.2005 | EN | Official Journal of the European Union | C 268/1 |
| --- | --- | --- | --- |

28.10.2005

EN

Official Journal of the European Union

C 268/1

---

Euro exchange rates (1)

27 October 2005

(2005/C 268/01)

1 euro=

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,2130 |
| JPY | Japanese yen | 139,89 |
| DKK | Danish krone | 7,4608 |
| GBP | Pound sterling | 0,67940 |
| SEK | Swedish krona | 9,5045 |
| CHF | Swiss franc | 1,5462 |
| ISK | Iceland króna | 73,25 |
| NOK | Norwegian krone | 7,8110 |
| BGN | Bulgarian lev | 1,9559 |
| CYP | Cyprus pound | 0,5735 |
| CZK | Czech koruna | 29,683 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 252,43 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,6964 |
| MTL | Maltese lira | 0,4293 |
| PLN | Polish zloty | 4,0060 |
| RON | Romanian leu | 3,6175 |
| SIT | Slovenian tolar | 239,51 |
| SKK | Slovak koruna | 39,033 |
| TRY | Turkish lira | 1,6413 |
| AUD | Australian dollar | 1,5983 |
| CAD | Canadian dollar | 1,4168 |
| HKD | Hong Kong dollar | 9,4058 |
| NZD | New Zealand dollar | 1,7161 |
| SGD | Singapore dollar | 2,0474 |
| KRW | South Korean won | 1 263,76 |
| ZAR | South African rand | 8,1508 |
| CNY | Chinese yuan renminbi | 9,8086 |
| HRK | Croatian kuna | 7,3850 |
| IDR | Indonesian rupiah | 12 154,26 |
| MYR | Malaysian ringgit | 4,579 |
| PHP | Philippine peso | 66,812 |
| RUB | Russian rouble | 34,4900 |
| THB | Thai baht | 49,452 |

Currency

Exchange rate

USD

US dollar

1,2130

JPY

Japanese yen

139,89

DKK

Danish krone

7,4608

GBP

Pound sterling

0,67940

SEK

Swedish krona

9,5045

CHF

Swiss franc

1,5462

ISK

Iceland króna

73,25

NOK

Norwegian krone

7,8110

BGN

Bulgarian lev

1,9559

CYP

Cyprus pound

0,5735

CZK

Czech koruna

29,683

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

252,43

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,6964

MTL

Maltese lira

0,4293

PLN

Polish zloty

4,0060

RON

Romanian leu

3,6175

SIT

Slovenian tolar

239,51

SKK

Slovak koruna

39,033

TRY

Turkish lira

1,6413

AUD

Australian dollar

1,5983

CAD

Canadian dollar

1,4168

HKD

Hong Kong dollar

9,4058

NZD

New Zealand dollar

1,7161

SGD

Singapore dollar

2,0474

KRW

South Korean won

1 263,76

ZAR

South African rand

8,1508

CNY

Chinese yuan renminbi

9,8086

HRK

Croatian kuna

7,3850

IDR

Indonesian rupiah

12 154,26

MYR

Malaysian ringgit

4,579

PHP

Philippine peso

66,812

RUB

Russian rouble

34,4900

THB

Thai baht

49,452

---

(1)

Source: reference exchange rate published by the ECB.

---

| 28.10.2005 | EN | Official Journal of the European Union | C 268/2 |
| --- | --- | --- | --- |

28.10.2005

EN

Official Journal of the European Union

C 268/2

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 September 2005 to 30 September 2005

(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93 (1))

(2005/C 268/02)

—   Issuing of a marketing authorization (Article 12 of Council Regulation (EEC) No 2309/93): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 19.9.2005 | Tarceva | Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, UK-Hertfordshire AL7 3AY | EU/1/05/311/001-003 | 21.9.2005 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

19.9.2005

Tarceva

Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, UK-Hertfordshire AL7 3AY

EU/1/05/311/001-003

21.9.2005

—   Modification of a marketing authorization (Article 12 of Council Regulation (EEC) No 2309/93): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 5.9.2005 | Ventavis | Schering AG, Müllerstraße 170-178, DE-13342 Berlin | EU/1/03/255//001-003 | 8.9.2005 |
| 5.9.2005 | Trazec | Novartis Europharm Limited, Wimblehurst Road, Horsham, UK-West Sussex RH12 5AB | EU/1/01/175/001-021 | 8.9.2005 |
| 5.9.2005 | Forsteo | Eli Lilly Nederland B.V., Grootslag 1-5, NL-3991 RA Houten | EU/1/03/247/001-002 | 7.9.2005 |
| 5.9.2005 | Starlix | Novartis Europharm Limited, Wimblehurst Road, Horsham, UK-West Sussex RH12 5AB | EU/1/01/174/001-021 | 8.9.2005 |
| 7.9.2005 | DaTSCAN | GE Healthcare Limited, UK-Little Chalfont Bucks HP7 9NA | EU/1/00/135/001-002 | 9.9.2005 |
| 7.9.2005 | Emtriva | Gilead Sciences International Limited, UK-Cambridge CB1 6GT | EU/1/03/261/001-003 | 9.9.2005 |
| 7.9.2005 | KOGENATE Bayer | Bayer AG, DE-51368 Leverkusen | EU/1/00/143/001-006 | 9.9.2005 |
| 7.9.2005 | Helixate NexGen | Bayer AG, DE-51368 Leverkusen | EU/1/00/144/001-003 | 9.9.2005 |
| 8.9.2005 | Nespo | Dompé Biotec S.p.A., Via San Martino, 12, IT-20122 Milano | EU/1/01/184/001-056 | 13.9.2005 |
| 8.9.2005 | Herceptin | Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, UK-Hertfordshire AL7 3AY | EU/1/00/145/001 | 13.9.2005 |
| 8.9.2005 | Xagrid | Shire Pharmaceutical Contracts Ltd, Hampshire International Business Park, Chineham, Basingstoke, UK-Hampshire RG24 8EP | EU/1/04/295/001 | 13.9.2005 |
| 8.9.2005 | Kivexa | Glaxo Group Ltd, Berkeley Avenue, Greenford, UK-Middlesex UB6 0NN | EU/1/04/298/001-002 | 13.9.2005 |
| 8.9.2005 | Ziagen | Glaxo Group Ltd, Greenford, UK-Middlesex UB6 0NN | EU/1/99/112/001-002 | 13.9.2005 |
| 8.9.2005 | Aranesp | Amgen Europe B.V., Minervum 7061, NL-4817 ZK Breda | EU/1/01/185/001-056 | 13.9.2005 |
| 8.9.2005 | Karvezide | Bristol-Myers Squibb Pharma EEIG, Uxbridge Business Park, Sanderson Road, UK-Uxbridge UD8 1DH | EU/1/98/085/001-020 | 13.9.2005 |
| 8.9.2005 | CoAprovel | Sanofi Pharma Bristol-Myers Squibb SNC, 174 avenue de France, FR-75013 Paris | EU/1/98/086/001-020 | 13.9.2005 |
| 8.9.2005 | PegIntron | Schering Plough Europe, Rue de Stalle, 73, BE-1180 Bruxelles — Stallestraat, 73, BE-1180 Brussel | EU/1/00/131/001-050 | 13.9.2005 |
| 8.9.2005 | ViraferonPeg | Schering Plough Europe, Rue de Stalle, 73, BE-1180 Bruxelles — Stallestraat, 73, BE-1180 Brussel | EU/1/00/132/001-050 | 13.9.2005 |
| 8.9.2005 | Raptiva | Serono Europe Limited, 56, Marsh Wall, UK-London E14 9TP | EU/1/04/291/001-002 | 14.9.2005 |
| 8.9.2005 | Pylobactell | Torbet Laboratories Limited, Unit 14D, Wendover Road, Rackheath Industrial Estate, Norwich, UK-Norfolk NR13 6LH | EU/1/98/064/001 | 13.9.2005 |
| 13.9.2005 | Infanrix Hexa | GlaxoSmithKline Biologicals S.A., rue de l'Institut 89, BE-1330 Rixensart | EU/1/00/152/001-018 | 14.9.2005 |
| 13.9.2005 | Somavert | Pfizer Limited, Sandwich, UK-Kent, CT13 9NJ | EU/1/02/240/001-004 | 14.9.2005 |
| 13.9.2005 | Hepsera | Gilead Sciences International Limited, UK-Cambridge CB1 6GT | EU/1/03/251/001 | 15.9.2005 |
| 13.9.2005 | Erbitux | Merck KGaA, Frankfurter Straße 250, DE-64293 Darmstadt | EU/1/04/281/001 | 14.9.2005 |
| 13.9.2005 | Dynepo | Shire Pharmaceutical Contracts Ltd, Hampshire International Business Park, Chineham, Basingstoke, UK-Hampshire RG24 8EP
  Aventis Pharma S.A., 20 Avenue Raymond Aron, Antony Cedex FR-92165 | EU/1/02/211/001-009 | 15.9.2005 |
| 13.9.2005 | Infanrix Penta | GlaxoSmithKline Biologicals s.a., rue de l'Institut 89, BE-1330 Rixensart | EU/1/00/153/001-010 | 14.9.2005 |
| 13.9.2005 | Mimpara | Amgen Europe B.V., Minervum 7061, NL-4817 ZK Breda | EU/1/04/292/001-012 | 14.9.2005 |
| 13.9.2005 | Avandamet | SmithKline Beecham plc, 980 Great West Road, Brentford, UK-Middlesex TW8 9GS | EU/1/03/258/013-014 | 14.9.2005 |
| 13.9.2005 | Karvea | Bristol-Myers Squibb Pharma EEIG, 141-149 Staines Road, UK-Hounslow TW3 3JA | EU/1/97/049/001-030 | 15.9.2005 |
| 13.9.2005 | Keppra | UCB S.A., Allée de la recherche, 60, BE-1070 Bruxelles — Researchdreef, 60, BE-1070 Brussel | EU/1/00/146/001-029 | 16.9.2005 |
| 13.9.2005 | Keppra | UCB S.A., Allée de la recherche, 60, BE-1070 Bruxelles — Researchdreef, 60, BE-1070 Brussel | EU/1/00/146/001-027 | 16.9.2005 |
| 13.9.2005 | Aprovel | Sanofi Pharma Bristol-Myers Squibb SNC, 174 avenue de France, FR-75013 Paris | EU/1/97/046/001-030 | 15.9.2005 |
| 15.9.2005 | Hepsera | Gilead Sciences International Limited, UK-Cambridge CB1 6GT | EU/1/03/251/001 | 20.9.2005 |
| 15.9.2005 | Cymbalta | Eli Lilly Nederland BV, Grootslag 1-5, NL-3991 RA Houten | EU/1/04/296/001-006 | 20.9.2005 |
| 15.9.2005 | Ariclaim | Boehringer Ingelheim International GmbH, Binger Straße 173, DE-55216 Ingelheim am Rhein | EU/1/04/283/001-007 | 20.9.2005 |
| 15.9.2005 | Yentreve | Eli Lilly Nederland B.V., Grootslag 1-5, NL-3991 RA Houten | EU/1/04/280/001-007 | 20.9.2005 |
| 15.9.2005 | Xeristar | Boehringer Ingelheim International GmbH, Binger Straße 173, DE-55216 Ingelheim am Rhein | EU/1/04/297/001-006 | 20.9.2005 |
| 15.9.2005 | Bonviva | Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, UK-Hertfordshire AL7 3AY | EU/1/03/265/003-004 | 20.9.2005 |
| 15.9.2005 | Bondenza | Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, UK-Hertfordshire AL7 3AY | EU/1/03/266/003-004 | 20.9.2005 |
| 15.9.2005 | Myocet | Elan Pharma International Ltd., WIL House, Shannon Business Park, Shannon, IE-County Clare | EU/1/00/141/001 | 20.9.2005 |
| 15.9.2005 | NovoMix | Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd | EU/1/00/142/004-005
  EU/1/00/142/009-010 | 20.9.2005 |
| 16.9.2005 | REYATAZ | Bristol-Myers Squibb Pharma EEIG, 141-149 Staines Road, UK-Hounslow TW3 3JA | EU/1/03/267/001-007 | 20.9.2005 |
| 19.9.2005 | Ariclaim | Boehringer Ingelheim International GmbH, Binger Straße 173, DE-55216 Ingelheim am Rhein | EU/1/04/283/001-007 | 21.9.2005 |
| 19.9.2005 | Arava | Aventis Pharma Deutschland GmbH, DE-65926 Frankfurt am Main | EU/1/99/118/001-010 | 21.9.2005 |
| 19.9.2005 | Yentreve | Eli Lilly Nederland B.V., Grootslag 1-5, NL-3991 RA Houten | EU/1/04/280/001-007 | 21.9.2005 |
| 19.9.2005 | Hexavac | Sanofi Pasteur MSD, SNC, 8, rue Jonas Salk, FR-69007 Lyon | EU/1/00/147/001-012 | 21.9.2005 |
| 22.9.2005 | Iscover | Bristol-Myers Squibb Pharma EEIG, Uxbridge Business Park, Sanderson Road, UK-Uxbridge UD8 1DH | EU/1/98/070/001a — 001b
  EU/1/98/070/002a — 002b
  EU/1/98/070/003a — 003b
  EU/1/98/070/004a — 001b | 26.9.2005 |
| 22.9.2005 | Plavix | Sanofi Pharma Bristol-Myers Squibb SNC, 174 avenue de France, FR-75013 Paris | EU/1/98/069/001a — 001b
  EU/1/98/069/002a — 002b
  EU/1/98/069/003a — 003b
  EU/1/98/069/004a — 001b | 26.9.2005 |
| 29.9.2005 | Remicade | Centocor B.V., Einsteinweg 101, NL-2333 CB Leiden | EU/1/99/116/001-003 | 4.10.2005 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

5.9.2005

Ventavis

Schering AG, Müllerstraße 170-178, DE-13342 Berlin

EU/1/03/255//001-003

8.9.2005

5.9.2005

Trazec

Novartis Europharm Limited, Wimblehurst Road, Horsham, UK-West Sussex RH12 5AB

EU/1/01/175/001-021

8.9.2005

5.9.2005

Forsteo

Eli Lilly Nederland B.V., Grootslag 1-5, NL-3991 RA Houten

EU/1/03/247/001-002

7.9.2005

5.9.2005

Starlix

Novartis Europharm Limited, Wimblehurst Road, Horsham, UK-West Sussex RH12 5AB

EU/1/01/174/001-021

8.9.2005

7.9.2005

DaTSCAN

GE Healthcare Limited, UK-Little Chalfont Bucks HP7 9NA

EU/1/00/135/001-002

9.9.2005

7.9.2005

Emtriva

Gilead Sciences International Limited, UK-Cambridge CB1 6GT

EU/1/03/261/001-003

9.9.2005

7.9.2005

KOGENATE Bayer

Bayer AG, DE-51368 Leverkusen

EU/1/00/143/001-006

9.9.2005

7.9.2005

Helixate NexGen

Bayer AG, DE-51368 Leverkusen

EU/1/00/144/001-003

9.9.2005

8.9.2005

Nespo

Dompé Biotec S.p.A., Via San Martino, 12, IT-20122 Milano

EU/1/01/184/001-056

13.9.2005

8.9.2005

Herceptin

Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, UK-Hertfordshire AL7 3AY

EU/1/00/145/001

13.9.2005

8.9.2005

Xagrid

Shire Pharmaceutical Contracts Ltd, Hampshire International Business Park, Chineham, Basingstoke, UK-Hampshire RG24 8EP

EU/1/04/295/001

13.9.2005

8.9.2005

Kivexa

Glaxo Group Ltd, Berkeley Avenue, Greenford, UK-Middlesex UB6 0NN

EU/1/04/298/001-002

13.9.2005

8.9.2005

Ziagen

Glaxo Group Ltd, Greenford, UK-Middlesex UB6 0NN

EU/1/99/112/001-002

13.9.2005

8.9.2005

Aranesp

Amgen Europe B.V., Minervum 7061, NL-4817 ZK Breda

EU/1/01/185/001-056

13.9.2005

8.9.2005

Karvezide

Bristol-Myers Squibb Pharma EEIG, Uxbridge Business Park, Sanderson Road, UK-Uxbridge UD8 1DH

EU/1/98/085/001-020

13.9.2005

8.9.2005

CoAprovel

Sanofi Pharma Bristol-Myers Squibb SNC, 174 avenue de France, FR-75013 Paris

EU/1/98/086/001-020

13.9.2005

8.9.2005

PegIntron

Schering Plough Europe, Rue de Stalle, 73, BE-1180 Bruxelles — Stallestraat, 73, BE-1180 Brussel

EU/1/00/131/001-050

13.9.2005

8.9.2005

ViraferonPeg

Schering Plough Europe, Rue de Stalle, 73, BE-1180 Bruxelles — Stallestraat, 73, BE-1180 Brussel

EU/1/00/132/001-050

13.9.2005

8.9.2005

Raptiva

Serono Europe Limited, 56, Marsh Wall, UK-London E14 9TP

EU/1/04/291/001-002

14.9.2005

8.9.2005

Pylobactell

Torbet Laboratories Limited, Unit 14D, Wendover Road, Rackheath Industrial Estate, Norwich, UK-Norfolk NR13 6LH

EU/1/98/064/001

13.9.2005

13.9.2005

Infanrix Hexa

GlaxoSmithKline Biologicals S.A., rue de l'Institut 89, BE-1330 Rixensart

EU/1/00/152/001-018

14.9.2005

13.9.2005

Somavert

Pfizer Limited, Sandwich, UK-Kent, CT13 9NJ

EU/1/02/240/001-004

14.9.2005

13.9.2005

Hepsera

Gilead Sciences International Limited, UK-Cambridge CB1 6GT

EU/1/03/251/001

15.9.2005

13.9.2005

Erbitux

Merck KGaA, Frankfurter Straße 250, DE-64293 Darmstadt

EU/1/04/281/001

14.9.2005

13.9.2005

Dynepo

Shire Pharmaceutical Contracts Ltd, Hampshire International Business Park, Chineham, Basingstoke, UK-Hampshire RG24 8EP

Aventis Pharma S.A., 20 Avenue Raymond Aron, Antony Cedex FR-92165

EU/1/02/211/001-009

15.9.2005

13.9.2005

Infanrix Penta

GlaxoSmithKline Biologicals s.a., rue de l'Institut 89, BE-1330 Rixensart

EU/1/00/153/001-010

14.9.2005

13.9.2005

Mimpara

Amgen Europe B.V., Minervum 7061, NL-4817 ZK Breda

EU/1/04/292/001-012

14.9.2005

13.9.2005

Avandamet

SmithKline Beecham plc, 980 Great West Road, Brentford, UK-Middlesex TW8 9GS

EU/1/03/258/013-014

14.9.2005

13.9.2005

Karvea

Bristol-Myers Squibb Pharma EEIG, 141-149 Staines Road, UK-Hounslow TW3 3JA

EU/1/97/049/001-030

15.9.2005

13.9.2005

Keppra

UCB S.A., Allée de la recherche, 60, BE-1070 Bruxelles — Researchdreef, 60, BE-1070 Brussel

EU/1/00/146/001-029

16.9.2005

13.9.2005

Keppra

UCB S.A., Allée de la recherche, 60, BE-1070 Bruxelles — Researchdreef, 60, BE-1070 Brussel

EU/1/00/146/001-027

16.9.2005

13.9.2005

Aprovel

Sanofi Pharma Bristol-Myers Squibb SNC, 174 avenue de France, FR-75013 Paris

EU/1/97/046/001-030

15.9.2005

15.9.2005

Hepsera

Gilead Sciences International Limited, UK-Cambridge CB1 6GT

EU/1/03/251/001

20.9.2005

15.9.2005

Cymbalta

Eli Lilly Nederland BV, Grootslag 1-5, NL-3991 RA Houten

EU/1/04/296/001-006

20.9.2005

15.9.2005

Ariclaim

Boehringer Ingelheim International GmbH, Binger Straße 173, DE-55216 Ingelheim am Rhein

EU/1/04/283/001-007

20.9.2005

15.9.2005

Yentreve

Eli Lilly Nederland B.V., Grootslag 1-5, NL-3991 RA Houten

EU/1/04/280/001-007

20.9.2005

15.9.2005

Xeristar

Boehringer Ingelheim International GmbH, Binger Straße 173, DE-55216 Ingelheim am Rhein

EU/1/04/297/001-006

20.9.2005

15.9.2005

Bonviva

Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, UK-Hertfordshire AL7 3AY

EU/1/03/265/003-004

20.9.2005

15.9.2005

Bondenza

Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, UK-Hertfordshire AL7 3AY

EU/1/03/266/003-004

20.9.2005

15.9.2005

Myocet

Elan Pharma International Ltd., WIL House, Shannon Business Park, Shannon, IE-County Clare

EU/1/00/141/001

20.9.2005

15.9.2005

NovoMix

Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd

EU/1/00/142/004-005

EU/1/00/142/009-010

20.9.2005

16.9.2005

REYATAZ

Bristol-Myers Squibb Pharma EEIG, 141-149 Staines Road, UK-Hounslow TW3 3JA

EU/1/03/267/001-007

20.9.2005

19.9.2005

Ariclaim

Boehringer Ingelheim International GmbH, Binger Straße 173, DE-55216 Ingelheim am Rhein

EU/1/04/283/001-007

21.9.2005

19.9.2005

Arava

Aventis Pharma Deutschland GmbH, DE-65926 Frankfurt am Main

EU/1/99/118/001-010

21.9.2005

19.9.2005

Yentreve

Eli Lilly Nederland B.V., Grootslag 1-5, NL-3991 RA Houten

EU/1/04/280/001-007

21.9.2005

19.9.2005

Hexavac

Sanofi Pasteur MSD, SNC, 8, rue Jonas Salk, FR-69007 Lyon

EU/1/00/147/001-012

21.9.2005

22.9.2005

Iscover

Bristol-Myers Squibb Pharma EEIG, Uxbridge Business Park, Sanderson Road, UK-Uxbridge UD8 1DH

EU/1/98/070/001a — 001b

EU/1/98/070/002a — 002b

EU/1/98/070/003a — 003b

EU/1/98/070/004a — 001b

26.9.2005

22.9.2005

Plavix

Sanofi Pharma Bristol-Myers Squibb SNC, 174 avenue de France, FR-75013 Paris

EU/1/98/069/001a — 001b

EU/1/98/069/002a — 002b

EU/1/98/069/003a — 003b

EU/1/98/069/004a — 001b

26.9.2005

29.9.2005

Remicade

Centocor B.V., Einsteinweg 101, NL-2333 CB Leiden

EU/1/99/116/001-003

4.10.2005

—   Withdrawal of a marketing authorization (Article 12 of Council Regulation (EEC) No 2309/93)

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 22.9.2005 | CEA-Scan | Immunomedics GmbH, Otto-Röhm-Straße 69, DE-64293 Darmstadt | EU/1/96/023/001 | 27.9.2005 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

22.9.2005

CEA-Scan

Immunomedics GmbH, Otto-Röhm-Straße 69, DE-64293 Darmstadt

EU/1/96/023/001

27.9.2005

—   Modification of a marketing authorization (Article 34 of Council Regulation (EEC) No 2309/93): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 19.9.2005 | Pirsue | PFIZER Ltd, Ramsgate Road, Sandwich, UK-Kent CT13 9NJ | EU/2/00/027/001-003 | 21.9.2005 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

19.9.2005

Pirsue

PFIZER Ltd, Ramsgate Road, Sandwich, UK-Kent CT13 9NJ

EU/2/00/027/001-003

21.9.2005

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

| The European Medicines Agency |
| --- |
| 7, Westferry Circus, Canary Wharf |
| UK-London E14 4HB |

The European Medicines Agency

7, Westferry Circus, Canary Wharf

UK-London E14 4HB

---

(1)  OJ L 214 of 24.8.1993, p. 1.

---

| 28.10.2005 | EN | Official Journal of the European Union | C 268/7 |
| --- | --- | --- | --- |

28.10.2005

EN

Official Journal of the European Union

C 268/7

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 September 2005 to 30 September 2005

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC (2))

(2005/C 268/03)

Issuing, maintenance or modification of a national marketing authorisation

| Date of the decision | Name(s) of the medicinal product | Holder(s) of the marketing authorization | Member State concerned | Date of notification |
| --- | --- | --- | --- | --- |
| 15.9.2005 | Lansopon | See Annex I | See Annex I | 19.9.2005 |
| 15.9.2005 | Lansoprazol HEXAL | See Annex II | See Annex II | 19.9.2005 |

Date of the decision

Name(s) of the medicinal product

Holder(s) of the marketing authorization

Member State concerned

Date of notification

15.9.2005

Lansopon

See Annex I

See Annex I

19.9.2005

15.9.2005

Lansoprazol HEXAL

See Annex II

See Annex II

19.9.2005

---

(1)  OJ L 311, 28.11.2001, p. 67.

(2)  OJ L 311, 28.11.2001, p. 1.

---

ANNEX I

LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANT, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES

| Member State | Marketing authorisation holder | Applicant | Invented name | Strength | Pharmaceutical form | Route of administration |
| --- | --- | --- | --- | --- | --- | --- |
| Belgium | — | HEXAL AG |
| Industriestraße 25 |
| DE-83607 Holzkirchen |

Member State

Marketing authorisation holder

Applicant

Invented name

Strength

Pharmaceutical form

Route of administration

Belgium

—

HEXAL AG

Industriestraße 25

DE-83607 Holzkirchen

Lansoprazole BEXAL 15 mg gélules gastro-resistantes

15 mg

Gastro-resistant capsule, hard

Oral use

Lansoprazole BEXAL 30 mg gélules gastro-resistantes

30 mg

Gastro-resistant capsule, hard

Oral use

Lansoprazol HEXAL

30 mg

Gastro-resistant capsule, hard

Oral use

Germany

—

| HEXAL AG |
| --- |
| Industriestraße 25 |
| DE-83607 Holzkirchen |

HEXAL AG

Industriestraße 25

DE-83607 Holzkirchen

Lansoprazol HEXAL 15 mg Hartkapseln

15 mg

Gastro-resistant capsule, hard

Oral use

Lansoprazol HEXAL 30 mg Hartkapseln

30 mg

Gastro-resistant capsule, hard

Oral use

Finland

| HEXAL AG |
| --- |
| Industriestraße 25 |
| DE-83607 Holzkirchen |

HEXAL AG

Industriestraße 25

DE-83607 Holzkirchen

—

Lansopon 15mg

15 mg

Gastro-resistant capsule, hard

Oral use

Lansopon 30 mg

30 mg

Gastro-resistant capsule, hard

Oral use

Luxembourg

—

| HEXAL AG |
| --- |
| Industriestraße 25 |
| DE-83607 Holzkirchen |

HEXAL AG

Industriestraße 25

DE-83607 Holzkirchen

Lansoprazol HEXAL 15 mg Hartkapseln

15 mg

Gastro-resistant capsule, hard

Oral use

Lansoprazol HEXAL 30 mg Hartkapseln

30 mg

Gastro-resistant capsule, hard

Oral use

---

ANNEX II

LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANT, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES

| Member State | Marketing authorisation holder | Applicant | Invented name | Strength | Pharmaceutical form | Route of administration |
| --- | --- | --- | --- | --- | --- | --- |
| Austria | — | HEXAL AG |
| Industriestraße 25 |
| DE-83607 Holzkirchen |

Member State

Marketing authorisation holder

Applicant

Invented name

Strength

Pharmaceutical form

Route of administration

Austria

—

HEXAL AG

Industriestraße 25

DE-83607 Holzkirchen

Lansohexal 15 mg — Hartkapseln

15 mg

Gastro-resistant capsule, hard

Oral use

Lansohexal 30 mg — Hartkapseln

30 mg

Gastro-resistant capsule, hard

Oral use

Denmark

—

| HEXAL AG |
| --- |
| Industriestraße 25 |
| DE-83607 Holzkirchen |

HEXAL AG

Industriestraße 25

DE-83607 Holzkirchen

Lansoprazol HEXAL

15 mg

Gastro-resistant capsule, hard

Oral use

Lansoprazol HEXAL

30 mg

Gastro-resistant capsule, hard

Oral use

Germany

—

| HEXAL AG |
| --- |
| Industriestraße 25 |
| DE-83607 Holzkirchen |

HEXAL AG

Industriestraße 25

DE-83607 Holzkirchen

Lansohexal 15 mg Hartkapseln

15 mg

Gastro-resistant capsule, hard

Oral use

Lansohexal 30 mg Hartkapseln

30 mg

Gastro-resistant capsule, hard

Oral use

Finland

| HEXAL AG |
| --- |
| Industriestraße 25 |
| DE-83607 Holzkirchen |

HEXAL AG

Industriestraße 25

DE-83607 Holzkirchen

—

Lansoprazol HEXAL 15mg

15 mg

Gastro-resistant capsule, hard

Oral use

Lansoprazol HEXAL 30 mg

30 mg

Gastro-resistant capsule, hard

Oral use

Sweden

—

| HEXAL AG |
| --- |
| Industriestraße 25 |
| DE-83607 Holzkirchen |

HEXAL AG

Industriestraße 25

DE-83607 Holzkirchen

Lansocid

15 mg

Gastro-resistant capsule, hard

Oral use

Lansocid

30 mg

Gastro-resistant capsule, hard

Oral use

---

| 28.10.2005 | EN | Official Journal of the European Union | C 268/10 |
| --- | --- | --- | --- |

28.10.2005

EN

Official Journal of the European Union

C 268/10

---

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 68/2001 of 12 January 2001 on the application of Articles 87 and 88 of the EC Treaty to training aid

(2005/C 268/04)

(Text with EEA relevance)

| Aid Number | XT 33/04 |
| --- | --- |
| Member State | United Kingdom |
| Region | London |
| Title of aid scheme or name of company receiving an individual aid | Customised Training Programme to Support Business Retention and New Investment |
| Legal basis | Regional Development Agency Act 1998 (as amended by the Greater London Authority Act 1999) |
| Annual expenditure planned under the scheme or overall amount of individual aid granted to the company | Aid scheme | Annual overall amount | GBP 1,45 million |
| Loans guaranteed | |
| Individual aid | Overall aid amount | |
| Loans guaranteed | |
| Maximum aid intensity | In conformity with Article 4(2)-(6) of the Regulation | Yes | |
| Date of implementation | From 19.4.2004 |
| Duration of scheme or individual aid award | Until 31.3.2006 |
| Objective of aid | General training | No |
| Specific training | Yes |
| Economic sectors concerned | All sectors eligible for training aid | Yes |
| Name and address of the granting authority | Name:
  London Development Agency |
| Address:





  Devon House |
| 58-60 St Katharine's Way |
| UK-London |
| E1W 1JX |

Aid Number

XT 33/04

Member State

United Kingdom

Region

London

Title of aid scheme or name of company receiving an individual aid

Customised Training Programme to Support Business Retention and New Investment

Legal basis

Regional Development Agency Act 1998 (as amended by the Greater London Authority Act 1999)

Annual expenditure planned under the scheme or overall amount of individual aid granted to the company

Aid scheme

Annual overall amount

GBP 1,45 million

Loans guaranteed

Individual aid

Overall aid amount

Loans guaranteed

Maximum aid intensity

In conformity with Article 4(2)-(6) of the Regulation

Yes

Date of implementation

From 19.4.2004

Duration of scheme or individual aid award

Until 31.3.2006

Objective of aid

General training

No

Specific training

Yes

Economic sectors concerned

All sectors eligible for training aid

Yes

Name and address of the granting authority

Name:

London Development Agency

Address:

Devon House

58-60 St Katharine's Way

UK-London

E1W 1JX

Large individual aid grants

In conformity with Article 5 of the Regulation

The measure excludes awards of aid or requires prior notification to the Commission of awards of aid, if the amount of aid granted to one enterprise for a single training project exceeds EUR 1 000 000.

N/A

| Aid No | XT 47/03 |
| --- | --- |
| Member State | United Kingdom |
| Region | North West |
| Title of aid scheme or name of company receiving individual aid | United Biscuits (UK) Ltd |
| Legal basis | Regional Development Agencies Act 1998 |
| Annual expenditure planned or overall amount of individual aid granted to the company | Aid scheme | Annual overall amount | |
| Loans guaranteed | |
| Individual aid | Overall aid amount | GBP 130 446 |
| Loans guaranteed | |
| Maximum aid intensity | In conformity with Article 4(2)-(6) of the Regulation | Yes | |
| Date of implementation | 1.12.2003 |
| Duration of the scheme or individual aid award | Until 31.12.2005 |
| Objective of aid | General training | Yes |
| Specific training | Yes |
| Economic sectors | All sectors eligible for training aid | Yes |
| Name and address of the granting authority | Name:
  North West Development Agency |
| Address:





  Renaissance House, PO Box 37 |
| Centre Park, Warrington |
| UK-Cheshire WA1 1XB |

Aid No

XT 47/03

Member State

United Kingdom

Region

North West

Title of aid scheme or name of company receiving individual aid

United Biscuits (UK) Ltd

Legal basis

Regional Development Agencies Act 1998

Annual expenditure planned or overall amount of individual aid granted to the company

Aid scheme

Annual overall amount

Loans guaranteed

Individual aid

Overall aid amount

GBP 130 446

Loans guaranteed

Maximum aid intensity

In conformity with Article 4(2)-(6) of the Regulation

Yes

Date of implementation

1.12.2003

Duration of the scheme or individual aid award

Until 31.12.2005

Objective of aid

General training

Yes

Specific training

Yes

Economic sectors

All sectors eligible for training aid

Yes

Name and address of the granting authority

Name:

North West Development Agency

Address:

Renaissance House, PO Box 37

Centre Park, Warrington

UK-Cheshire WA1 1XB

Large individual aid grants

In conformity with Article 5 of the Regulation

The measure excludes awards of aid or requires prior notification to the Commission of awards of aid, if the amount of aid granted to one enterprise for a single training project exceeds EUR 1 million.

Yes

| Aid No | XT 51/04 |
| --- | --- |
| Member State | Germany |
| Region | Bavaria |
| Title of aid scheme or name of company receiving individual aid | Impulse
  Agentur für Projektentwicklung und -management |
| Legal basis | Bay HO, VO (EG) Nr. 1260/1999, VO (EG) Nr. 1784/1999, EPPD zu Ziel 2, Programmergänzung zu Ziel 2 |
| Annual expenditure planned or overall amount of individual aid granted to the company | Aid scheme | Annual overall amount | |
| Loans guaranteed | |
| Individual aid | Overall aid amount | EUR 304 290 |
| Loans guaranteed | |
| Maximum aid intensity | In conformity with Article 4(2)-(7) of the Regulation | Yes | |
| Date of implementation | 6.7.2004 |
| Duration of the scheme or individual aid award | Until 31.12.2005 |
| Objective of aid | General training | Yes |
| Specific training | |
| Economic sectors concerned | All sectors eligible for training aid | Yes |
| Name and address of the granting authority | Name:
  Bayerisches Landesamt für Versorgung und Familienförderung |
| Address:
  Hegelstraße 4, DE-95447 Bayreuth |
| Large individual aid grants | In conformity with Article 5 of the Regulation | Yes | |

Aid No

XT 51/04

Member State

Germany

Region

Bavaria

Title of aid scheme or name of company receiving individual aid

Impulse

Agentur für Projektentwicklung und -management

Legal basis

Bay HO, VO (EG) Nr. 1260/1999, VO (EG) Nr. 1784/1999, EPPD zu Ziel 2, Programmergänzung zu Ziel 2

Annual expenditure planned or overall amount of individual aid granted to the company

Aid scheme

Annual overall amount

Loans guaranteed

Individual aid

Overall aid amount

EUR 304 290

Loans guaranteed

Maximum aid intensity

In conformity with Article 4(2)-(7) of the Regulation

Yes

Date of implementation

6.7.2004

Duration of the scheme or individual aid award

Until 31.12.2005

Objective of aid

General training

Yes

Specific training

Economic sectors concerned

All sectors eligible for training aid

Yes

Name and address of the granting authority

Name:

Bayerisches Landesamt für Versorgung und Familienförderung

Address:

Hegelstraße 4, DE-95447 Bayreuth

Large individual aid grants

In conformity with Article 5 of the Regulation

Yes

| Aid No | XT 52/04 |
| --- | --- |
| Member State | Germany |
| Region | Bavaria |
| Title of aid scheme or name of company receiving individual aid | Grundig Akademie für Wirtschaft und Technik Gemeinnützige Stiftung e. V., Beuthener Straße 45, DE-90471 Nürnberg |
| Legal basis | Bay HO, VO (EG) Nr. 1260/1999, VO (EG) Nr. 1784/1999, EPPD zu Ziel 2, Programmergänzung zu Ziel 2 |
| Annual expenditure planned or overall amount of individual aid granted to the company | Aid scheme | Annual overall amount | |
| Loans guaranteed | |
| Individual aid | Overall aid amount | EUR 527 299 |
| Loans guaranteed | |
| Maximum aid intensity | In conformity with Article 4(2)-(7) of the Regulation | Yes | |
| Date of implementation | 21.6.2004 |
| Duration of the scheme or individual aid award | Until 30.9.2006 |
| Objective of aid | General training | Yes |
| Specific training | |
| Economic sectors concerned | All sectors eligible for training aid | Yes |
| Name and address of the granting authority | Name:
  Bayerisches Landesamt für Versorgung und Familienförderung |
| Address:
  Hegelstraße 4, DE-95447 Bayreuth |
| Large individual aid grants | In conformity with Article 5 of the Regulation | Yes | |

Aid No

XT 52/04

Member State

Germany

Region

Bavaria

Title of aid scheme or name of company receiving individual aid

Grundig Akademie für Wirtschaft und Technik Gemeinnützige Stiftung e. V., Beuthener Straße 45, DE-90471 Nürnberg

Legal basis

Bay HO, VO (EG) Nr. 1260/1999, VO (EG) Nr. 1784/1999, EPPD zu Ziel 2, Programmergänzung zu Ziel 2

Annual expenditure planned or overall amount of individual aid granted to the company

Aid scheme

Annual overall amount

Loans guaranteed

Individual aid

Overall aid amount

EUR 527 299

Loans guaranteed

Maximum aid intensity

In conformity with Article 4(2)-(7) of the Regulation

Yes

Date of implementation

21.6.2004

Duration of the scheme or individual aid award

Until 30.9.2006

Objective of aid

General training

Yes

Specific training

Economic sectors concerned

All sectors eligible for training aid

Yes

Name and address of the granting authority

Name:

Bayerisches Landesamt für Versorgung und Familienförderung

Address:

Hegelstraße 4, DE-95447 Bayreuth

Large individual aid grants

In conformity with Article 5 of the Regulation

Yes

---

| 28.10.2005 | EN | Official Journal of the European Union | C 268/13 |
| --- | --- | --- | --- |

28.10.2005

EN

Official Journal of the European Union

C 268/13

---

UNIFORM APPLICATION OF THE COMBINED NOMENCLATURE (CN)

(Classification of goods)

(2005/C 268/05)

Explanatory notes adopted in accordance with the procedure defined in Article 10(1) of Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff (1)

The explanatory notes to the Combined Nomenclature of the European Communities (2) shall be amended as follows:

On page 321 insert the following text:

with laser reading system

This subheading covers radio-broadcast receivers, combined with a sound recording or reproducing apparatus with a laser reading system, whether or not combined with other sound recording or reproducing apparatus (for example of the cassette-type) or a clock.’

with laser reading system

The explanatory notes to subheading 8527 13 10 apply, mutatis mutandis.’

with laser reading system

The explanatory notes to subheading 8527 13 10 apply, mutatis mutandis.’

with laser reading system

The explanatory notes to subheading 8527 13 10 apply, mutatis mutandis.’

---

(1)  OJ L 256, 7.9.1987, p. 1. Regulation as last amended by Council Regulation (EC) No 493/2005 (OJ L 82, 31.3.2005, p. 1).

1

(2)  OJ C 256, 23.10.2002, p. 1.

2

---

| 28.10.2005 | EN | Official Journal of the European Union | C 268/14 |
| --- | --- | --- | --- |

28.10.2005

EN

Official Journal of the European Union

C 268/14

---

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 70/2001 of 12 January 2001 on the application of Articles 87 and 88 of the EC Treaty to State aid to small and medium-sized enterprises

(2005/C 268/06)

(Text with EEA relevance)

Aid No: XS 125/03

Member State: Germany

Region: Saxony-Anhalt

Title of aid scheme: Special programme for building the information society in Saxony-Anhalt

Legal basis:

| — | Landeshaushaltsordnung (LHO) vom 30.4.1991 (GVBl. LSA S. 45), insbesondere die Verwaltungsvorschriften zu § 44 LHO des Landes Sachsen-Anhalt; |
| --- | --- |

—

Landeshaushaltsordnung (LHO) vom 30.4.1991 (GVBl. LSA S. 45), insbesondere die Verwaltungsvorschriften zu § 44 LHO des Landes Sachsen-Anhalt;

| — | Verordnung (EG) Nr. 70/2001 der Kommission vom 12.1.2001 über die Anwendung der Artikel 87 und 88 EG-Vertrag auf staatliche Beihilfen an kleine und mittlere Unternehmen (ABl. L 10 vom 13.1.2002, S. 33) |
| --- | --- |

—

Verordnung (EG) Nr. 70/2001 der Kommission vom 12.1.2001 über die Anwendung der Artikel 87 und 88 EG-Vertrag auf staatliche Beihilfen an kleine und mittlere Unternehmen (ABl. L 10 vom 13.1.2002, S. 33)

Annual expenditure planned under the scheme: Approx. EUR 2,5 million

Maximum aid intensity:

—   Investment grants

The aid intensity is limited to a maximum of 50 % gross (35 % gross regional aid plus 15 % gross SME bonus).

—   Consultancy aid

towards expenditure on services provided by outside consultants to existing or new SMEs and expenditure on assessing feasibility. The aid intensity is limited to 50 % gross of the eligible expenditure

Date of implementation:

Duration of scheme: Until 31.12.2004

Objective:

| — | Supporting small and medium-sized enterprises in the development, use and application of digital information, communication and media technologies |
| --- | --- |

—

Supporting small and medium-sized enterprises in the development, use and application of digital information, communication and media technologies

| — | Improving competitive conditions for SMEs |
| --- | --- |

—

Improving competitive conditions for SMEs

| — | Promoting the development of regional networks of companies in technology-oriented sectors |
| --- | --- |

—

Promoting the development of regional networks of companies in technology-oriented sectors

| — | Increasing the region's attractiveness to businesses |
| --- | --- |

—

Increasing the region's attractiveness to businesses

| — | Helping to improve equal opportunities for women, men and disadvantaged groups in access to training and employment |
| --- | --- |

—

Helping to improve equal opportunities for women, men and disadvantaged groups in access to training and employment

Economic sector(s) concerned: All economic sectors. All services

Comments: The following are excluded:

Activities relating to the manufacture, processing and marketing of goods listed in Annex 1 to the EC Treaty

Aid for export-related activities

Aid which is conditional on the use of indigenous products rather than imported goods.

Aid to the steel, synthetic fibres, motor vehicle and shipbuilding industries

Since special rules apply to agriculture, fisheries and aquaculture and transport and since even small amounts of aid to those sectors might fulfil the criteria of Article 87(1) of the EC Treaty, the sectors in question are excluded from the scheme.

The steel, synthetic fibres, motor vehicle and shipbuilding industries are excluded owing, among other things, to the fact that appropriate measures have been agreed in relation to regional investment aid

Name and address of the granting authority:

| Landesförderinstitut Sachsen-Anhalt |
| --- |
| Gruppe Sonderprogramm |
| Domplatz 12 |
| DE-39104 Magdeburg |

Landesförderinstitut Sachsen-Anhalt

Gruppe Sonderprogramm

Domplatz 12

DE-39104 Magdeburg

Other information:

| Ministerium für Wirtschaft und Arbeit |
| --- |
| Referat 35 |
| Hasselbachstraße 4 |
| DE-39104 Magdeburg |

Ministerium für Wirtschaft und Arbeit

Referat 35

Hasselbachstraße 4

DE-39104 Magdeburg

---

| 28.10.2005 | EN | Official Journal of the European Union | C 268/15 |
| --- | --- | --- | --- |

28.10.2005

EN

Official Journal of the European Union

C 268/15

---

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 2204/2002 of 12 December 2002 on the application of Articles 87 and 88 of the EC Treaty to State aid for employment

(2005/C 268/07)

(Text with EEA relevance)

Aid No: XE 9/03

Member State: Italy

Region: Campania

Title of aid scheme: Recruitment of disadvantaged workers

‘IN LA’ project — Jobs for the long-term unemployed in the Province of Naples.

Under this project firms are given a grant of EUR 5 164,66 for each long-term unemployed person they recruit on a permanent basis or fixed-term contract of at least twelve months' duration, in the tourism and agriculture sectors

Legal basis: L. 23.12.1996, n. 662, art. 2 comma 203, lett. b)

Intesa Istituzionale di programma del 16.9.2003

D. D. 19 giugno 2003

Annual expenditure planned: EUR 15 494 000

Maximum aid intensity under: Article 5: recruitment of disadvantaged workers

The maximum special grant for each beneficiary firm is 50 % of the wage costs calculated over a period of one year following recruitment. Both figures are gross, i.e. before taxes. Under Article 8(4) the special grant may be cumulated with other national or Community incentives applicable for the same recruitment, given that these are measures for getting the long-term unemployed back into work; in any case the cumulation of aid cannot exceed the ceilings laid down in Regulation (EC) No 2204/2002, therefore the gross aid intensity resulting from the cumulation cannot exceed 100 % of the wage costs over any period for which the worker or workers are employed.

This means that, in addition to the grant of EUR 5 164,66, for every person recruited on a permanent basis firms are also entitled to the incentives for recruitment of long-term unemployed persons on a permanent full-time or part-time basis under Article 8(9) of Law No 407/90 (100 % exemption from employer's social security contributions for 36 months in the case of firms operating in the Mezzogiorno and craft firms; 50 % exemption from the same contributions for the same period in the case of private-sector employers such as professional practices, foundations, associations, etc. in the Mezzogiorno, and also firms in North Central Italy).

The incentives under Article 8(9) of Law No 407/90 do not apply to recruitment in the tourist industry or in agriculture if the contract is for a fixed term, even if for 12 months or more

Date of implementation:

Duration of scheme:

Objective of aid: Article 5: recruitment of disadvantaged workers

Recruitment of some 3 000 long-term unemployed persons in the Province of Naples at serious risk of social exclusion

Economic sector(s) concerned: All EC sectors

Name and address of the granting authority:

| Ministero del lavoro e delle Politiche Sociali |
| --- |
| Direzione Generale per l'Impiego, l'Orientamento e la Formazione |
| Via Fornovo, 8 |
| IT-00192 Roma |
| Tel. (0039-06) 36 75 50 60 |
| e.mail: segreteriadgimpiego@welfare.gov.it |

Ministero del lavoro e delle Politiche Sociali

Direzione Generale per l'Impiego, l'Orientamento e la Formazione

Via Fornovo, 8

IT-00192 Roma

Tel. (0039-06) 36 75 50 60

e.mail: segreteriadgimpiego@welfare.gov.it

---

| 28.10.2005 | EN | Official Journal of the European Union | C 268/16 |
| --- | --- | --- | --- |

28.10.2005

EN

Official Journal of the European Union

C 268/16

---

Non-opposition to a notified concentration

(Case COMP/M.3735 — Finmeccanica/AMS)

(2005/C 268/08)

(Text with EEA relevance)

On 14 March 2005, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32005M3735. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32005M3735. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex)

---

| 28.10.2005 | EN | Official Journal of the European Union | C 268/16 |
| --- | --- | --- | --- |

28.10.2005

EN

Official Journal of the European Union

C 268/16

---

Non-opposition to a notified concentration

(Case COMP/M.3649 — Finmeccanica/Baes Avionics & Communications)

(2005/C 268/09)

(Text with EEA relevance)

On 14 March 2005, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32005M3649. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32005M3649. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex)

---